CN Stock MarketDetailed Quotes

600568 Zhong Zhu Healthcare Holding

Watchlist
  • 1.51
  • +0.06+4.14%
Not Open Dec 4 15:00 CST
3.01BMarket Cap-16777P/E (TTM)

About Zhong Zhu Healthcare Holding Company

The company, formerly known as Hubei Qianjiang Pharmaceutical Co., Ltd., was listed on the Shanghai Stock Exchange on May 18, 2001. It is a national ophthalmic drug production base and ophthalmic drug listed company. The company's main business involves healthcare, pharmaceuticals, and real estate. The main products include pharmaceutical aspects: pearl bright eye drops, sodium cromoglycate eye drops, acyclovir eye drops, etc.; medical aspects: oxybenzazole hydrochloride eye drops, acyclovir dispersible tablets, gatifloxacin tablets, Hepast ultrasound liver cirrhosis detector, infusion heater, Moon God full body gamma knife; real estate: Zhongzhushang County Project, Mountain and Sea Phase II Project, Zhongzhu Field Project, and Chunxiaoyueju Phase II Project in Doumen District, Zhuhai City.

Company Profile

Short Name-AST中珠
Symbol-A600568
Company NameZhongZhu Healthcare Holding Co.，Ltd
Listing DateMay 18, 2001
Issue Price9.70
Shares Offered35.00M share(s)
FoundedJun 27, 1994
Listed ExchangeSH Stock Exchange
Legal Representativejige ye
General Managerhua ma
Secretaryweibin zhang
Accounting FirmDahua Certified Public Accountants (Special General Partnership)
Securities Representativewei li
Legal CounselShanghai AllBright (Wuhan) Law Firm
Employees53
Phone0728-6402068
Office Address8th Floor, Block 5, Renheng Binhai Center, No. 1 South Couple Road, Zhuhai
Zip Code519020
Registered AddressNo. 1, Zhanghua South Road, Qianjiang City, Hubei Province
Fax0728-6402099
Emailzz600568@126.com
Websitehttp://www.zz600568.com
Business License420000000013743
BusinessTechnology promotion services; software development; computer system integration; basic software services; sales of electronic products, computer software, hardware and auxiliary equipment, instruments and medical devices (Class I only). (Market players independently choose business projects and carry out business activities according to law; for projects subject to approval according to law, they carry out business activities according to the approved content after approval by the relevant departments; they are not allowed to engage in business activities prohibited or restricted by national and municipal industrial policies.)

Company Executives

  • Name
  • Position
  • Salary
  • jige ye
  • Chairman, Directors, Strategy Committee Convener, Nomination Committee Members
  • 1.43M
  • baolong qiao
  • Directors, VP, Strategy Committee Member
  • 530.00K
  • weibin zhang
  • Directors, Board Secretary, Member of the Remuneration and Assessment Committee
  • 654.00K
  • yucheng ceng
  • Directors, VP, Strategy Committee Member
  • 230.00K
  • you wu
  • Directors, Audit Committee Member
  • --
  • jianming sheng
  • Directors, Nomination Committee Members, Strategy Committee Member, Member of the Remuneration and Assessment Committee, Audit Committee Member
  • --
  • baozhu zhang
  • Independent Directors, Audit Committee Convener, Member of the Remuneration and Assessment Committee, Nomination Committee Members, Strategy Committee Member
  • 16.00K
  • yibin ceng
  • Independent Directors, Audit Committee Member, Member of the Remuneration and Assessment Committee, Nomination Committee Convener
  • 96.00K
  • lang chen
  • Independent Directors, Nomination Committee Members, Remuneration and Assessment Committee Convener, Audit Committee Member
  • 96.00K
  • wei li
  • Securities Affairs Representative
  • 119.00K
  • zhongyang shi
  • Chairman of the Supervisory Board, Auditors
  • --
  • jian li
  • Auditors
  • --
  • hua ma
  • President
  • --
  • peichao si
  • VP
  • 982.00K
  • guanghui huang
  • Executive Vice President
  • 982.00K
  • liang tan
  • Chief Financial Officer
  • 668.00K
  • qin xu
  • Employee Supervisors
  • 668.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data